Home  |  Site Map  |  Glossary  | Contact
Text size: AA   AA   AA

Pipeline

  PRODUCTS INDICATION STATUS
Visudyne®
Monotherapy

Certain forms of choroidal neo-vascularization (CNV) due to wet age-related macular degeneration (AMD). Also, CNV due to pathological myopia or ocular histoplasmosis

Market

Visudyne
Followed by an Anti-VEGF

Reduced Fluence Visudyne-Anti-VEGF-
Dexamethasone in combination for AMD lesions (RADICAL Study)

Phase II

Latanoprost   Punctal Plug Delivery System   (L-PPDS)

Safety study of the L-PPDS in subjects with ocular hypertension (OH) or open-angle glaucoma (OAG) (PPL GLAU 03)

Study of the effects of artificial tears on the response to the L-PPDS in subjects with OH or OAG (PPL GLAU 04)

Study of punctal placement of the L-PPDS (PPL GLAU 05)

Phase II

Olopatadine

Punctal Plug Delivery System   (O-PPDS)

Allergic Conjunctivitis Preclinical
QLT091568 Glaucoma Preclinical

QLT091001           Synthetic Retinoid

Leber Congenital Amourosis (LCA)             (RET IRD 01)

Phase I

   

 

 

Visudyne® is a registered trademark of Novartis AG
 
Copyright © 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking